483 Chartwell Pharmaceuticals Sep 2012

483 Chartwell Pharmaceuticals Sep 2012

Satheesh Thomas FDA$119.00 - Available Now

FDA investigators audited the Chartwell Pharmaceuticals - Congers, NY, United States facility and issued inspectional observations (via FDA 483) on 19 Sep 2012.

Product details

  • Category: Human Drugs
  • Inspection end: 19 Sep 2012
  • Location: Congers, United States
  • FEI: 3008897678
Add To Cart